Xiamen Amoytop Biotech Co., Ltd. (SHA:688278)
China
· Delayed Price · Currency is CNY 85.60
+0.10 (0.12%)
Aug 15, 2025, 3:00 PM CST
Xiamen Amoytop Biotech Market Cap
Xiamen Amoytop Biotech has a market cap or net worth of 34.82 billion as of August 15, 2025. Its market cap has increased by 49.83% in one year.
Market Cap
34.82B
Enterprise Value
34.02B
Revenue
2.95B
Ranking
n/a
PE Ratio
39.67
Stock Price
85.60
Market Cap Chart
Since January 17, 2020, Xiamen Amoytop Biotech's market cap has increased from 14.36B to 34.82B, an increase of 142.49%. That is a compound annual growth rate of 17.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 34.82B | 16.67% |
| Dec 31, 2024 | 29.85B | 40.15% |
| Dec 29, 2023 | 21.30B | 34.47% |
| Dec 30, 2022 | 15.84B | 32.96% |
| Dec 31, 2021 | 11.91B | -14.13% |
| Dec 31, 2020 | 13.87B | -3.40% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 419.19B |
| WuXi AppTec | 287.87B |
| Shenzhen Mindray Bio-Medical Electronics | 286.01B |
| Sichuan Biokin Pharmaceutical | 126.19B |
| Zhangzhou Pientzehuang Pharmaceutical., | 121.00B |
| Aier Eye Hospital Group | 120.01B |
| Shanghai United Imaging Healthcare | 104.90B |
| Yunnan Baiyao Group Co.,Ltd | 99.92B |